Search

Search Constraints

You searched for: Author/Creator Woodworth, Deborah A.

Search Results

1. Agreement between local and central reading of endoscopic disease activity in ulcerative colitis: results from the tofacitinib OCTAVE trials. Issue 11 (6th October 2021)

2. Efficacy of Tofacitinib in Patients With Ulcerative Colitis by Prior Tumor Necrosis Factor Inhibitor Treatment Status: Results From OCTAVE Induction and Maintenance Studies: 640. (October 2017)

3. Impact of Baseline Corticosteroid Therapy on Tofacitinib Induction Efficacy and Infection Risk in Patients With Ulcerative Colitis: Data From Global Clinical Trials: 706. (October 2019)

4. Predictors of Delayed Response to Tofacitinib: Results of the OCTAVE Open Study for Delayed Responders: 798. (October 2019)

5. Symptomatic Improvement Within 3 Days With Tofacitinib Induction Therapy in Patients With Ulcerative Colitis: Results From OCTAVE Induction 1 and 2: 609. (October 2017)

6. Tofacitinib Efficacy in Patients With Moderate to Severe Ulcerative Colitis: Subgroup Analyses of OCTAVE Induction 1 & 2 and OCTAVE Sustain by 5‐Aminosalicylates Use: 836. (October 2019)

7. Tofacitinib for Maintenance Therapy in Patients With Active Ulcerative Colitis in the Phase 3 OCTAVE Sustain Trial: Results by Local and Central Endoscopic Assessments: 607. (October 2017)